Home › Cardiotoxicity › New Jersey
Cardiotoxicity clinical trials in New Jersey
4 studies for Cardiotoxicity are looking for participants at sites in New Jersey.
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056A Study of Blood Pressure Control During Cancer Treatment
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · Women · Updated May 14, 2026 · NCT06023576Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
- Trinitas Hospital and Comprehensive Cancer Center, Elizabeth
- RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, Hamilton
- RWJBarnabas Health - - Jersey City Medical Medical, Jersey City
- and 7 more
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 14, 2025 · NCT05559164S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Morristown Medical Center, Morristown
- Overlook Hospital, Summit
- Holy Name Hospital, Teaneck
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.